Neil E Kay

Title: Neil E Kay: Innovator in Cancer Treatment

Introduction

Neil E Kay is a prominent inventor based in St. Louis Park, MN (US). He has made significant contributions to the field of cancer treatment, holding 2 patents that focus on innovative methods and materials for combating various forms of cancer. His work is particularly relevant in the realm of immunotherapy and hematologic cancers.

Latest Patents

One of Neil E Kay's latest patents involves methods and materials for treating cancer. This document outlines techniques for treating mammals with cancer, specifically those with CD19 positive extracellular vesicles (EVs) and small EVs in the tumor microenvironment. The patent describes methods for treating blood cancers by administering cancer immunotherapies, such as chimeric antigen receptor (CAR) T-cell therapies. Another significant patent focuses on the treatment of hematologic cancers, detailing methods that include the administration of EGCG alongside purine nucleoside analogs and alkylating agents. This patent particularly addresses the treatment of chronic lymphocytic leukemia (CLL) and acute lymphocytic leukemia (ALL).

Career Highlights

Neil E Kay is associated with the Mayo Foundation for Medical Education and Research, where he continues to advance his research and innovations in cancer treatment. His work has garnered attention for its potential to improve therapeutic outcomes for patients suffering from various blood cancers.

Collaborations

Some of his notable coworkers include Saad J Kenderian and Michelle J Cox, who collaborate with him in the pursuit of innovative cancer therapies.

Conclusion

Neil E Kay's contributions to cancer treatment through his patents and research at the Mayo Foundation for Medical Education and Research highlight his commitment to improving patient care. His innovative approaches in the field of oncology are paving the way for new therapeutic strategies.